178 related articles for article (PubMed ID: 12795049)
1. Cyclooxygenase-2 and skin carcinogenesis.
Fürstenberger G; Marks F; Müller-Decker K
Prog Exp Tumor Res; 2003; 37():72-89. PubMed ID: 12795049
[No Abstract] [Full Text] [Related]
2. Cyclooxygenase-2: a molecular target for chemoprevention of epithelial tumors of skin and colon.
Müller-Decker K; Charyalertsak S; Albert C; Reinerth G; Marks F; Fürstenberger G
Adv Exp Med Biol; 2002; 507():445-8. PubMed ID: 12664624
[No Abstract] [Full Text] [Related]
3. The role of COX-2 in breast and cervical cancer.
Dannenberg AJ; Howe LR
Prog Exp Tumor Res; 2003; 37():90-106. PubMed ID: 12795050
[No Abstract] [Full Text] [Related]
4. Prostaglandin endoperoxide H synthases-1 and -2.
Smith WL; Dewitt DL
Adv Immunol; 1996; 62():167-215. PubMed ID: 8781269
[No Abstract] [Full Text] [Related]
5. Cyclooxygenase-2: a target for the prevention and treatment of cancers of the upper digestive tract.
Altorki NK; Subbaramaiah K; Dannenberg AJ
Prog Exp Tumor Res; 2003; 37():107-23. PubMed ID: 12795051
[No Abstract] [Full Text] [Related]
6. [Progress in the study of cyclooxygenase].
Zhu H; Yang ZM
Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):81-3. PubMed ID: 15127608
[No Abstract] [Full Text] [Related]
7. Prostaglandins and renal damage.
Navarro JF
J Am Soc Nephrol; 1996 Aug; 7(8):1245-6. PubMed ID: 8866420
[No Abstract] [Full Text] [Related]
8. [Cyclooxygenases in the spinal cord and the relationship with pain].
Li SQ; Li WB
Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):359-60. PubMed ID: 14992024
[No Abstract] [Full Text] [Related]
9. Cyclooxygenase 2 induction: molecular mechanism and pathophysiologic roles.
Wu KK
J Lab Clin Med; 1996 Sep; 128(3):242-5. PubMed ID: 8783630
[No Abstract] [Full Text] [Related]
10. Prime suspect.
Manuel J
Environ Health Perspect; 1997 Jan; 105(1):28-9. PubMed ID: 9074875
[No Abstract] [Full Text] [Related]
11. A role for cyclooxygenase-1 in neuropathic pain?
Zeilhofer HU; Brune K
Anesthesiology; 2003 Nov; 99(5):1043-4. PubMed ID: 14576535
[No Abstract] [Full Text] [Related]
12. [Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer].
Buecher B; Heymann MF; Blottière HM
Gastroenterol Clin Biol; 2001 Nov; 25(11):967-78. PubMed ID: 11845047
[No Abstract] [Full Text] [Related]
13. Aspirin use and potential mechanisms for colorectal cancer prevention.
Williams CS; Smalley W; DuBois RN
J Clin Invest; 1997 Sep; 100(6):1325-9. PubMed ID: 9294096
[No Abstract] [Full Text] [Related]
14. The promise of coxibs: how far have we progressed?
Schumacher HR
J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S1-4. PubMed ID: 11992742
[No Abstract] [Full Text] [Related]
15. Cyclooxygenase-2 inhibitors and atherosclerosis.
Belton O; Fitzgerald D
J Am Coll Cardiol; 2003 May; 41(10):1820-2. PubMed ID: 12767670
[No Abstract] [Full Text] [Related]
16. COX-2 and colon cancer.
Taketo MM
Inflamm Res; 1998 Oct; 47 Suppl 2():S112-6. PubMed ID: 9831333
[TBL] [Abstract][Full Text] [Related]
17. [Physiopathological and therapeutic study of collagen diseases based on results of clinical tests--role of prostaglandins].
Sano H
Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2438-45. PubMed ID: 9922664
[No Abstract] [Full Text] [Related]
18. [COX-2 expression in gastric cancers].
Sakamoto C
Nihon Rinsho; 2001 Apr; 59 Suppl 4():598-603. PubMed ID: 11424449
[No Abstract] [Full Text] [Related]
19. The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors.
Szczeklik A; Sanak M
Clin Exp Allergy; 2002 Mar; 32(3):339-42. PubMed ID: 11940059
[No Abstract] [Full Text] [Related]
20. COX-2 inhibitors: a review.
Houston AM; Teach SJ
Pediatr Emerg Care; 2004 Jun; 20(6):396-9; quiz 400-2. PubMed ID: 15179150
[No Abstract] [Full Text] [Related]
[Next] [New Search]
